For the larger research view, see the CJC-1295 + Ipamorelin stack guide on each peptide's role, research, and safety notes
GLP-1 receptor agonists were first developed to treat diabetes and are now widely used for weight loss
1 or 2 mg of DSIP was intravenously injected into 4 anesthetized dogs with blood samples taken at 5-minute intervals
In the LIVE trial, liraglutide treatment resulted in no change in left ventricular systolic function, whereas liraglutide related to an increase in heart rate and more serious cardiac adverse events among chronic heart failure patients with and without type 2 diabetes [45]
High cost of GLP-1 drugs and affordability challenges hinder the market expansion
Costs for brand-name Zepbound run around $349 per month at the lowest dose through the manufacturer direct program, and many patients face costs of $1,000 or more when insurance will not cover it